HomeBTAI • NASDAQ
add
BioXcel Therapeutics Inc
Previous close
$2.54
Day range
$2.50 - $2.65
Year range
$1.17 - $13.28
Market cap
51.28M USD
Avg Volume
1.86M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 120.00K | -89.13% |
Operating expense | 15.86M | -9.25% |
Net income | -19.19M | -131.20% |
Net profit margin | -15.99K | -2,027.01% |
Earnings per share | -2.45 | 27.08% |
EBITDA | -15.78M | 3.58% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.44M | -69.02% |
Total assets | 25.79M | -60.59% |
Total liabilities | 133.46M | -4.49% |
Total equity | -107.67M | — |
Shares outstanding | 14.56M | — |
Price to book | -0.16 | — |
Return on assets | -123.16% | — |
Return on capital | -466.84% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -19.19M | -131.20% |
Cash from operations | -12.58M | 45.74% |
Cash from investing | — | — |
Cash from financing | 137.00K | -97.42% |
Net change in cash | -12.44M | 30.40% |
Free cash flow | -9.25M | 44.58% |
About
Founded
2017
Headquarters
Website
Employees
37
